Clinical Trial Update: Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating terminal warm blood cardioplegia for myocardial protection in complex congenital heart surgery using Histidin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Histidine-Tryptophan-Ketoglutarate cardioplegia (histidine-tryptophan-ketoglutarate cardioplegia)
• Terminal Warm Blood Cardioplegia (warm blood cardioplegia)

Snippet

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia | Conditions: Congenital Heart Disease | Phase 2 | Status: UNKNOWN